chrisvoncsefalvay/vaers-outcomes huggingface dataset:
erythma at site of vaccination right deltoid about 12 hrs after shot. It progressed to vesicles in center.  I saw her at 9 pm 11/27/2007.4" erythmatous ring with raised edge central vesicles with on about 1"x1/3" denuded oozing slightly brown scabbed surrounded by slightly mor intnse red.  Area very itchy not much pain
After my second shot I have not been able to smell. Will this end.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. On an unspecified date, after his second shot he have not been able to smell. He enquired whether will this end. At the time of this report, the outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a Licensed Practical Nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 13-FEB-2018, the patient was vaccinated with an improperly stored dose of Oka-Merck rHA PROQUAD with lot # N022972 and expiration date 19-FEB-2019 (Strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis reconstituted with MERCK STERILE DILUENT that was properly stored. There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 6°F to 14°F degrees Fahrenheit for 158 hours 39 minutes and 15°F to 46°F degrees Fahrenheit for 343 hours 29 minutes. There was a digital data logger involved, but there was no previous temperature excursion. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1803USA006667: US-009507513-1803USA006668: US-009507513-1803USA006669: US-009507513-1803USA006670.
Shoulder injury;   Two hours after injection, experienced severe pain in left arm with no mobility.  Called Pharmacy and was advised that "it might be frozen shoulder"...  take anti inflammatory.   Unable to take anti-inflammatories due to kidney cancer resulting in 1/2 of one functioning kidney and complete removal of other.  Followed up with PCP.
On the night of the vaccine, I had a very bad headache. I went to see the doctor in September. I was referred to Neurologist and he performed MRI. Neurologist prescribed Amitriptyline 20 mg and Diclofenac 75 mg twice daily. Neither medication works. I have an appointment scheduled with Neurologist on 21st of April 2022.
Swollen upper right arm 3-4 inches in diameter, raised, bright red, itchy and the onset was Thursday, 2-11-2021...8 days post injection. Adverse symptoms beginning to recede today, 2-15-2021
Patient felt throat "closing up" within 15 minutes of vaccination.  Had had similar reaction to Tdap vaccine in April.  Patient refused transport to ER; she said she would go to the ER with her boyfriend after leaving the vaccination clinic.  O2 sats were stable throughout her time in the clinic.
We both got our shot at the same time on March 17, 2021. Then on March 22, 2021 at 9:20 PM my husband suffered cardiac arrest and a seizure. His heart was revived however, due to lack of oxygen to his brain he suffered brain damage and never regained consciousness and passed on 4/3/21 with acute respiratory failure.
PEDIATRIC BOOSTER ADMINISTERED INSTEAD OF ADULT BOOSTER. PATIENT & DR BEING NOTIFIED. PATIENT WILL RETURN FOR ADULT BOOSTER.
Sudden onset of left eye swelling and his eye is almost swollen shut. No difficulty breathing, swallowing or drooling.
pt stated that she experienced severe shortness of breath, and a hot feeling several hours after the vaccine.  She stated that she does have an inhaler that she almost never uses, but did use  today. The inhaler did help her with her breathing. She also took 2 tablets of benadryl 25mg.  I asked to call her Dr also to inform them of allergic reaction to the flu shot. She stated that she has never had any reaction to the shot in the past.
This spontaneous report as received from a registered nurse refers to a 19 year old patient (unspecified gender). On 29-JUN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (dose and route were not provided) (lot # K008931 exp. 04-MAR-2017; lot # K009482 exp. 06-MAR-2017) which was exposed to below 36F for 361.81 hours. The nurse was requesting assistance in determining revaccination. In addition, excursion below 32F (31.2F) started on 13-JUL-2015. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
24hr p/vax pt felt area where typhoid inj given was hot, itchy & swollen;lasting noc felt sl flushed & arm very sore;this AM felt flushed & noticed red rash about upper chest area-1hr later p/coming to clinic rash arms, trunk & face;
Given nasal FLUMIST in office at 3:30 pm. At around 7pm after patient was done swimming she noticed hives and red blotches all over. No fever or trouble breathing. Called on call and told to give BENADRYL, after BENADRYL patient was fine, hives went away.
Headache, body ache, fatigue, high temp but not fever level, sore arm.
Within 5 minutes of receiving vaccine, patient became lightheaded and diaphoretic.  Patient vasovagal.   Feet were propped up, patient returned to baseline with 5 minutes of episode.  Was released into the care of her boyfriend.
Patient woke up and was not feeling well, went into parents room and collapsed lost consciousness briefly then was confused until seen in ER.
Had felt chilled most of the day and around 8:30 the chills became extreme.  Also felt feverish and slight headache.  Was shaking badly.  Took an excederin and got in bed.  In about one hour, the symptoms stopped and I began to feel better.  I drank a whole bottle of water as I felt dehydrated.  Slept through the night and was ok the  next day.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. No information about medical history, concurrent conditions was reported for the patients. On an unknown date the patients were vaccinated with unspecified number of improperly stored doses of PEDVAXHIB lot # K026533, expiration date 07-AUG-2017 (strength, route unspecified). No adverse effects reported. No product quality complaint was involved. This is one of the several reports from the same source. Additional information has been requested.
Hard knot on injection side, spreading over next days to 13cm diameter circle, all red and hard; tender, no meds given.
Information has been received on 05-FEB-2019 from a lawyer and a female patient regarding a case in litigation. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported) on or about 2015 at a medical center as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster, also known as shingles, and other complications. The patient was treated at a medical center for a vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the vaccine ZOSTAVAX and/or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Initial and follow up information has been received from a physician and a Licensed Practical Nurse (L.P.N.) and concerning a 24 week old male infant (previously reported as 16 week old) with lesion on head from birth who on 05-JAN-2007 was vaccinated with Pneumovax 23 instead of Prevnar. The office was unable to determine the cause of this possible error. On 06-JAN-2007 the patient developed redness in both legs and fever and went to ER. In follow up the physician mentioned that patient developed fever 104 o and redness at site. On 07-JAN-2007 patient recovered. On 10-MAR-2007, the patient was evaluated and in his office visit and was given 2 months above without reactions noted. Additional information is not expected.
father stated 14MAR97 pt has red, nonraised rash generalized over body;pt recv 3rd dose of havrix on 12MAR97;denies fever or other sx other than itching;advised to be seen by MD;
Pt had two self limited generalized seizures with fever (tonic-clonic) within 24 hours of immunization. Each lasted less than 10 minutes.
Mom noted 3AM t104 given APAP & sponge bath; temp remained 104; began pediaprophen & sponge baths 15APR92; 6AM t103; 8AM t99 remained nl since then;
fever to 102 ax started w/in 2 hrs of vax; 10-15 minutes generalized sz @ 1900 on 27AUG92 amt of fever @ sz unk; seen by MD 28AUG92 nl exam, nl CBC-still febrile by history;
MyocarditisHeart Pain, it is getting worse over time paired with chest pains, muscle pains throughout body, arm pains; MyocarditisHeart Pain, it is getting worse over time paired with chest pains, muscle pains throughout body, arm pains; MyocarditisHeart Pain, it is getting worse over time paired with chest pains, muscle pains throughout body, arm pains; MyocarditisHeart Pain, it is getting worse over time paired with chest pains, muscle pains throughout body, arm pains; MyocarditisHeart Pain, it is getting worse over time paired with chest pains, muscle pains throughout body, arm pains; This is a spontaneous report from a contactable consumer. A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: Unknown), via an unspecified route of administration on 25Aug2021 17:00 (age at the time of vaccination was 28 years old as dose number unknown, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. It was reported that no other vaccine in four weeks and no other medications in two weeks. It was reported that covid prior vaccination was no, covid tested post vaccination was no. It was reported that patient had no known allergies. The patient experienced myocarditis heart pain, it was getting worse over time paired with chest pains, muscle pains throughout body, arm pains on 25Aug2021.Therapeuitc measure were taken as no as a result of events. The outcome of events was not recovered.   The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow-up.
Woke up around 2:30am on 8/14  with severe aches in my jaw, neck, middle of back, hips, knees, ankles, pain and a feeling of fullness in my left armpit, and pain in my elbow and wrist on my left arm but not my right. When I got up I could feel a large lump in my armpit and it was very tender, and when I looked it is very visible (at least golf ball size). This continued through Saturday, I took ibuprofen and rested, keeping a pillow between my arm and my side as I could not comfortably put my arm down. When I woke up Sunday 8/15, the aches in my joints were gone, but the lump under my armpit is still there, still about the size of a golf ball. It is still a bit tender, the fullness feeling is not as much.
Pulmonary embolism; I have suspected side effects from a shot; Pericarditis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 17Nov2021 as dose number unknown (booster), single (Lot number: JH8028) at the age of 55 years for covid-19 immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing), notes: Other Conditions: No. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary immunization completed: Manufacturer: Unknown), for Covid-19 Immunization. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown"; PERICARDITIS (medically significant), outcome "unknown", described as "I have suspected side effects from a shot; Pericarditis". The patient underwent the following laboratory tests and procedures: Fibrin D dimer: Negative, notes: Date: Not Provided; Result: Negative; Unit: Not Provided.Consumer stated, that he had suspected side effects from a shot. The side effect was diagnosed with Pericarditis, which he knew is a rare side effect noted for the mRNA vaccines but the time difference is not quite that would classically expect from the side effects in the vaccine. So because he took that last vaccine the booster shot.   No follow-up attempts are possible. No further information is expected.
Patient was diagnosed with peripartum cardiomyopathy roughly within a month of receiving her Covid vaccine.  She does report significant shortness of breath prior to delivery via C-section.  She reports that she received her Covid vaccine in September 2021 while pregnant.
sore arm. Arm soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 84-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd October 2020, the patient received the 1st dose of Shingrix. On 22nd October 2020, 6 hrs after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm and experienced a sore arm.  The reporter did not consent to follow-up.
56 year old female had warmth and edema at the injection site after each of the first four anthrax vaccines.  This was accompanied by axillary lymphadenopathy, generalized myalgias, stiff joints, and flu-like symptoms.  After the second dose, initiated pretreatment with an oral antihistamine and Advil for the subsequent doses.  After each of the first three doses she had symptoms for 3  4 days and then they completely resolved.  These symptoms did not affect her ability to do her job. On 8 Sep 03 she received the fourth dose of anthrax vaccine.  She developed all of the same symptoms as with previous doses.  On 11 Sep 03 she had worsening pain in her knees, L>R.  By the fourth day, both knees were inflamed, and edematous, L>R.  She could not walk up or down stairs or bear full weight on the left leg.  Her left knee began to "buckle" intermittently.  As a result, she tore the meniscus on the left.  She was diagnosed with arthritis by a civilian doctor after X-rays were taken.  A MRI was ordered and she was sent to an Orthopedic doctor.  The MRI was normal except for the arthritis.  She received three steroid injections into the knee joint without any change in symptoms.  By this time, her right knee was getting worse and she tore the meniscus on the right.  She has undergone arthroscopy on both knees which confirmed the arthritis diagnosis.  The left knee has subsequently been injected with synthetic cushioning which has also been ineffective in relieving the symptoms.  The pain varies from a level of 1 to 7 out of 10 on any given day.  Walking and going down stairs makes the pain worse.  To avoid worsening of pain, repositioning while sitting is frequently required.  Also, if she turns the wrong way in her sleep, the pain will wake her up.  She is currently taking Bextra 20 mg a day with some pain relief, but the pain never completely resolves.   On 20 Jul 04 She received anthrax dose #5.  She had redness and swelling at the injection site that measured approximately 10 cm and was accompanied by axillary lymphadenopathy.  The nodule that appeared at the injection site was present for approximately 2 months.
Patient was given expired Monovalent Pfizer 0.3 ml via IM patient had NO adverse reactions or any side effects. Notified patient of medication error, stated that she felt perfectly fine.
w/in 5hr of vax lt deltoid pt noted low pack pains, gen myalgias, arthralgias, pain on breathing, localized rash that spread to chest;no n/v/diarrhea;no eval until 2 days later;anterior chest rash following felt achy still;
1145 patient reported feeling sleepy, states that she had breakfast at 9 am and think her blood sugar may be low. Patient talkative, Gatorade given, patient reports feeling better, 1150 patient assisted to stand , reports feeling sleepy and dizzy, transported to  medical tent via wheelchair. VSS, glucose 154, patient talkative consuming drink, denies symptoms. 12:00  Emergency Contact  notified  of event, she will come to site. 12 : 12 Patient c/o of feeling sleepy, encourage to continue drinking, refused transport to emergency room for evaluation, consumes 3 pieces of chocolate candy, reports feeling better. Talkative with no s/s of distress giving writer instructing on making breakfast casserole.  12: 15 patient daughter present, patient denies any symptoms. Daughter instructed writer that this event may be an attention seeking behaviors that patient often have.  Patient denies any issues, stands without symptoms, discharge to care via wheelchair.
Name listed on paperwork - Recombinant Zoster, Right eye when blinking spiderwebs appear then they disappear,  vision has decreased in focus, when holding finger in front of face with right eye he sees wiggles /wavy around the finger. With left eye the outline in sharp. Has seen Ophthalmologist, neuro Ophthalmologist. Had the flu shot the same day, not information on the flu details.
No additional adverse events; the patient received a fourth dose of GARDASIL 9; on 16-AUG-18 the patient received the first dose of GARDASIL 9/ the patient received the third dose of GARDASIL 9 on 21-AUG-2019; This spontaneous report was received from a health care professional (HCP), referring to a patient of unknown age. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not reported.  On 16-AUG-2018, at the age of 22-year-old the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, route of administration, and anatomical location were not reported; lot number and expiration date were unknown by the reporter) as prophylaxis.   On 19-OCT-2018, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, route of administration, and anatomical location were not reported; lot number and expiration date were unknown by the reporter) as prophylaxis.   On 21-AUG-2019, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, route of administration, and anatomical location were not reported; lot number and expiration date were unknown by the reporter) as prophylaxis (inappropriate schedule of product administration).   On 12-FEB-2019, the patient was vaccinated with the fourth dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, route of administration, and anatomical location were not reported; lot number and expiration date were unknown by the reporter) as prophylaxis (extra dose administered).  No additional adverse events.
Fatigue (Dose 1 & 2) Headache  (Dose 1 & 2) Body aches  (Dose 1 & 2) Sweats  (Dose 2 only) Reynaud's flares while inside  (Dose 2 only) Aphthous Ulcers (Dose 2 only) Rash/Hives (Dose 1 only)
This spontaneous report was received from a physician via a company representative reporting to a patient of unknown gender and age. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX injection, 19400 PFU)plaque-forming-units)(lot number, expiration date, dose were not provided), subcutaneous in the arm. There were no concomitant medications reported. The physician stated that the patient had reaction after receiving the ZOSTAVAX. He reported that his patient called to say that the vaccinated arm was red and swollen (Peripheral swelling), (Erythema). The outcome of the events was unknown. Additional information has been requested.
This is one case out of a cumulative total of 213 cases solicited from the EDSS database during the surveillance period from 01 January 2010 to 16 September 2013. These 213 cases represent children who received 3 or more doses of sanofi pasteur vaccine; cases of pertussis disease in children who received DTaP combination vaccines from other manufacturers are not reported as per study protocol. A case of pertussis disease in a four year-old female subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received four doses of PENTACEL; dose one lot number C3287AA received on 04 June 2009, dose two lot number C3299AA received on 14 August 2009, dose three lot number C3471AA received on 09 November 2009 and dose four lot number not reported on 29 October 2010 (routes and sites of administration for all doses not reported). The subject developed cold-like symptoms on 14 August 2013, approximately 33 months after the last dose. On 21 August 2013, the subject developed a cough and paroxysmal cough with whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 04 September 2013. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of Azithromycin starting on 04 September 2013 for five days. The subject was not hospitalized. At the time of final contact on 06 September 2013, the subject's cough was still persisting. The duration of the cough was reported at that time as 16 days. According to the investigator, this case was epidemiologically linked to a laboratory confirmed case. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
This patient's mother states the child developed a low grade fever after 24 hours. Then developed repetitive hand movements after 10 days which lasted "quite a while". The child did not seem to be aware of hand movements. He kept a fever 3 weeks and had a loss of appetite. This client was not seen by a physician but he obtained a medical exemption for Hep B from a cousin who is a physician.
24 hrs p/vax pt exp migraine cont x 15 days also photosensitivity all the time;
Pt got quarter-sized rash on back, very itchy, painful which grew to 4 inch rash which was raised- benadryl not helping, went to dermatologist who prescribed betamethasone cream, which decreased the size of rash- still experiencing side effects from rash
Rash covering torso, chest, back and neck.  Started 7-6-2021, stilling have 7-12-2021
Had soreness and swelling at injection site for approximately 48 hours after injection.  Then developed "COVID arm" on day 8 - itchy, red welt at injection site.  Hot and swollen, painful to touch.  No other symptoms present.
Patient reports developing red rash over injection site that was "like a hive." Rash spread to chest. Associated with itching. No pain. Resolved after 4 days without intervention.
Patient reports around 5 days after receiving Moderna vaccine he experienced fever, diarrhea, n/v and SOB.  Pt  presented 4/07/21 to LGH ED with unremarkable blood work and negative chest x-ray, Covid negative- Pt discharged. 4/12/21 pt represented to LGH ED for some concerns and worsening sob with talking and walking and found to have PE and pneumonia